Pick two tickers to compare their income statements as flow diagrams, one shared scale for both.
Key numbers
PFE
Pfizer Inc. Q2 FY2026 income statement
Revenue
$15.0B
Net loss
$248.0M
Net margin
-1.6%
LLY
Eli Lilly and Company Q3 FY2026 income statement
Revenue
$24.4B
Net income
$6.5B
Net margin
+26.4%
PFE's net margin is 28.1 points lower than LLY's.
PFE
Pfizer Inc. Q2 FY2026 income statement
USD, quarter ended 2026-06-28
LLY
Eli Lilly and Company Q3 FY2026 income statement
USD, quarter ended 2026-09-30
Eli Lilly and Company Q3 FY2026 income statementFlow diagram with 8 nodes and 7 flows for Eli Lilly and Company Q3 FY2026 income statement. Values: Revenue US$24.4B, Cost of Revenue US$8.1B, Gross Profit US$16.3B, Operating Expenses US$7.4B, Operating Income US$8.9B, Other Expense US$505M, Tax US$2B, Net Income US$6.5B.RevenueUS$24.4B+39% Y/YCost of Revenue(US$8.1B)+170% Y/Y33% of revenueGross ProfitUS$16.3B+12% Y/Y67% marginOperating Expenses(US$7.4B)+19% Y/YR&D 17% | SG&A 13% of revenue30% of revenueOperating IncomeUS$8.9B+6% Y/Y37% marginOther Expense(US$505M)-56% Y/Y2% of revenueTax(US$2B)+18% Y/Y8% of revenueNet IncomeUS$6.5B+16% Y/Y26% marginProfitCostsTax and deductions